Is BioNTech SE (BNTX) a Buy, Sell, or Hold?
BioNTech SE
NASDAQ:BNTX
$91.99 USD
$1.59 (1.76%)
- Volume
- 742.45K
- Average Volume
- 958.47K
- Market Capitalization
- $23.26B
- P/E Ratio
- -15.66
- Dividend Yield
- 0.00%
- Price Target
- $135.00
- Year High
- $124.00
- Year Low
- $79.52
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.80
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
10
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
1
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 50000
BNTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BNTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Low-Friedrich Iris Katharina | director: | 2026-06-26 | 0 | 2026-06-26 | |
| Schaffert Susanne | director: | 2026-06-26 | 0 | 2026-06-26 | |
| Zapata Gomez Ramon | officer: Chief Financial Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Zapata Gomez Ramon | officer: Chief Financial Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Ryan James Timothy Patrick | officer: See remarks. | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Ryan James Timothy Patrick | officer: See remarks. | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Poetting Sierk | officer: Chief Operating Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Poetting Sierk | officer: Chief Operating Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Jimenez Kylie | officer: Chief People Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Jimenez Kylie | officer: Chief People Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Hanekamp Annemarie | officer: Chief Commercial Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Hanekamp Annemarie | officer: Chief Commercial Officer | 2026-05-12 | A-Award | 0 | 2026-05-13 |
| Poetting Sierk | officer: Chief Operating Officer | 2026-04-22 | S-Sale | 110.5592 | 2026-04-23 |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-04-13 | |
| Blackwood Nicola Claire | director: | 2026-03-18 | 0 | 2026-03-25 | |
| Morawietz Anja | director | 2026-03-18 | 0 | 2026-03-25 | |
| Morawietz Anja | director | 2026-03-18 | 0 | 2026-03-25 | |
| Staudigl Rudolf | director | 2026-03-18 | 0 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2027-05-22 | 113.94 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2029-05-28 | 0 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2025-05-12 | 185.23 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2026-05-31 | 152.1 | 2026-03-25 | |
| Sahin Ugur | 10 percent owner, officer: Chief Executive Officer | 2029-05-27 | 0 | 2026-03-25 | |
| Zapata Gomez Ramon | officer | 2026-03-18 | 0 | 2026-03-25 | |
| Ryan James Timothy Patrick | officer: See remarks. | 2026-03-18 | 0 | 2026-03-25 | |
| Ryan James Timothy Patrick | officer: See remarks. | 2029-05-28 | 0 | 2026-03-25 | |
| Ryan James Timothy Patrick | officer: See remarks. | 2029-05-27 | 0 | 2026-03-25 | |
| Ryan James Timothy Patrick | officer: See remarks. | 2027-12-08 | 0 | 2026-03-25 | |
| Jimenez Kylie | officer | 2026-03-18 | 0 | 2026-03-25 | |
| Motschmann Michael | 2026-03-18 | 0 | 2026-03-18 | ||
| Poetting Sierk | officer: Chief Operating Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2027-05-22 | 113.94 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2029-05-28 | 0 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2025-05-12 | 185.23 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2026-05-31 | 152.1 | 2026-03-18 | |
| Poetting Sierk | officer: Chief Operating Officer | 2029-05-27 | 0 | 2026-03-18 | |
| Jeggle Helmut Wolfgang | director | 2026-03-18 | 0 | 2026-03-18 | |
| Jeggle Helmut Wolfgang | director | 2026-03-18 | 0 | 2026-03-18 | |
| Tureci Ozlem | officer: Chief Medical Officer | 2027-05-22 | 113.94 | 2026-03-18 | |
| Tureci Ozlem | officer: Chief Medical Officer | 2029-05-28 | 0 | 2026-03-18 | |
| Tureci Ozlem | officer: Chief Medical Officer | 2025-05-12 | 185.23 | 2026-03-18 | |
| Tureci Ozlem | officer: Chief Medical Officer | 2026-05-31 | 152.1 | 2026-03-18 | |
| Tureci Ozlem | officer: Chief Medical Officer | 2029-05-27 | 0 | 2026-03-18 | |
| Wandschneider Ulrich | director | 2026-03-18 | 0 | 2026-03-18 | |
| Hanekamp Annemarie | officer: Chief Commercial Officer | 2029-05-28 | 0 | 2026-03-18 | |
| Hanekamp Annemarie | officer: Chief Commercial Officer | 2029-05-27 | 0 | 2026-03-18 |